Alopecia Thesis Topics for MD/DNB Dermatology

alopecia thesis topics

This page covers clinically feasible alopecia thesis ideas for MD Dermatology candidates, including androgenetic alopecia, alopecia areata, telogen effluvium, cicatricial alopecia, traction alopecia, paediatric hair loss, trichoscopy, quality of life and early treatment outcomes that can usually be completed within one thesis period using patients, clinical examination and investigations already available in a dermatology department. The emphasis is on alopecia thesis topics, alopecia research topics, dermatology alopecia protocol and dermatology alopecia synopsis choices that can be converted into a focused protocol or synopsis without making the project dependent on non-routine resources.

Last reviewed and updated: September 2026 · 2026–27 admissions

Androgenetic Alopecia

  1. Clinical and trichoscopic profile of male androgenetic alopecia and its correlation with Hamilton-Norwood grading: a cross-sectional analytical study.
  2. Clinical and trichoscopic profile of female pattern hair loss and its correlation with Ludwig grading: a cross-sectional analytical study.
  3. Correlation of hair shaft diameter diversity on trichoscopy with clinical severity of androgenetic alopecia: a cross-sectional analytical study.
  4. Comparison of trichoscopic findings between early and advanced male androgenetic alopecia: a comparative cross-sectional study.
  5. Comparison of trichoscopic findings in female pattern hair loss and chronic telogen effluvium: a comparative cross-sectional study.
  6. Diagnostic accuracy of trichoscopy in differentiating female pattern hair loss from chronic telogen effluvium using clinical assessment and hair pull test as the routine reference standard: a diagnostic accuracy study.
  7. Association of family history with age at onset and severity of male androgenetic alopecia: a cross-sectional analytical study.
  8. Association of body mass index with severity of androgenetic alopecia in adult men: a cross-sectional analytical study.
  9. Association of central obesity with severity of male androgenetic alopecia: a cross-sectional analytical study.
  10. Prevalence of metabolic syndrome among men with androgenetic alopecia and its association with Hamilton-Norwood grade: a cross-sectional analytical study.
  11. Comparison of metabolic syndrome frequency in men with early-onset androgenetic alopecia and age-matched dermatology controls: a case-control study.
  12. Association of dyslipidaemia with severity of androgenetic alopecia among patients undergoing routine metabolic evaluation: a cross-sectional analytical study.
  13. Relationship between smoking and severity of male androgenetic alopecia: a cross-sectional analytical study.
  14. Dermatology Life Quality Index impairment in patients with androgenetic alopecia and its correlation with clinical severity: a cross-sectional analytical study.
  15. Comparison of quality-of-life impairment between male androgenetic alopecia and female pattern hair loss: a comparative cross-sectional study.
  16. Association of duration of androgenetic alopecia with clinical grade and trichoscopic severity: a cross-sectional analytical study.
  17. Early clinical and trichoscopic response to routinely prescribed topical minoxidil in androgenetic alopecia over twelve weeks: a prospective observational study.
  18. Baseline clinical and trichoscopic predictors of twelve-week response to topical minoxidil in androgenetic alopecia: a prospective observational study.
  19. Adherence to topical minoxidil in androgenetic alopecia and factors associated with poor adherence: a cross-sectional analytical study.
  20. Frequency and pattern of adverse effects associated with routinely prescribed topical minoxidil in androgenetic alopecia: a cross-sectional observational study.

Alopecia Areata

  1. Clinical and epidemiological profile of alopecia areata and its association with Severity of Alopecia Tool score: a cross-sectional observational study.
  2. Trichoscopic features of alopecia areata and their correlation with Severity of Alopecia Tool score: a cross-sectional analytical study.
  3. Association of black dots, exclamation mark hairs and broken hairs on trichoscopy with clinical activity of alopecia areata: a cross-sectional analytical study.
  4. Comparison of trichoscopic findings in active and stable alopecia areata: a comparative cross-sectional study.
  5. Correlation between hair pull test positivity and trichoscopic markers of activity in alopecia areata: a cross-sectional analytical study.
  6. Association of disease duration with severity and clinical pattern of alopecia areata: a cross-sectional analytical study.
  7. Association of family history with extent and recurrence history of alopecia areata: a cross-sectional analytical study.
  8. Clinical profile of patients with alopecia areata with and without nail involvement: a comparative cross-sectional study.
  9. Association of nail changes with Severity of Alopecia Tool score in alopecia areata: a cross-sectional analytical study.
  10. Onychoscopic findings in alopecia areata and their association with severity of scalp involvement: a cross-sectional analytical study.
  11. Frequency of atopic disorders among patients with alopecia areata and their association with disease severity: a cross-sectional analytical study.
  12. Association of thyroid disorders with severity of alopecia areata among patients undergoing clinically indicated thyroid evaluation: a cross-sectional analytical study.
  13. Comparison of quality-of-life impairment in localised and extensive alopecia areata: a comparative cross-sectional study.
  14. Correlation of Severity of Alopecia Tool score with Dermatology Life Quality Index in adults with alopecia areata: a cross-sectional analytical study.
  15. Clinical predictors of extensive alopecia areata among patients attending a dermatology outpatient department: a case-control study.
  16. Dermoscopic differentiation of alopecia areata from trichotillomania: a comparative cross-sectional study.
  17. Diagnostic accuracy of trichoscopy in differentiating alopecia areata from trichotillomania using clinicopathological diagnosis where clinically indicated as the reference standard: a diagnostic accuracy study.
  18. Early clinical and trichoscopic response of localised alopecia areata to routinely administered intralesional corticosteroid therapy over twelve weeks: a prospective observational study.
  19. Baseline trichoscopic predictors of twelve-week response to routine intralesional corticosteroid therapy in localised alopecia areata: a prospective observational study.
  20. Frequency and pattern of immediate and early adverse effects following routine intralesional corticosteroid treatment for alopecia areata: a prospective observational study.

Telogen Effluvium and Diffuse Hair Loss

  1. Clinical and trichoscopic profile of acute telogen effluvium in adult women: a cross-sectional observational study.
  2. Clinical and trichoscopic profile of chronic telogen effluvium and its correlation with hair pull test findings: a cross-sectional analytical study.
  3. Comparison of clinical and trichoscopic findings in acute and chronic telogen effluvium: a comparative cross-sectional study.
  4. Frequency and pattern of identifiable precipitating factors in patients with telogen effluvium: a cross-sectional observational study.
  5. Association of recent febrile illness with severity of hair shedding in acute telogen effluvium: a case-control study.
  6. Association of recent weight loss and dietary restriction with telogen effluvium in adult women: a case-control study.
  7. Association of psychological stress with severity of hair shedding in telogen effluvium: a cross-sectional analytical study.
  8. Relationship between hair pull test positivity and patient-reported shedding severity in telogen effluvium: a cross-sectional analytical study.
  9. Comparison of hair pull test findings in telogen effluvium and female pattern hair loss: a comparative cross-sectional study.
  10. Trichoscopic differentiation of chronic telogen effluvium from early female pattern hair loss: a comparative cross-sectional study.
  11. Diagnostic accuracy of trichoscopy for differentiating chronic telogen effluvium from female pattern hair loss using clinical diagnosis and hair pull test as the routine reference standard: a diagnostic accuracy study.
  12. Association of haemoglobin level with severity of hair shedding among women with telogen effluvium undergoing routine complete blood count testing: a cross-sectional analytical study.
  13. Association of anaemia with clinical severity of telogen effluvium in adult women: a cross-sectional analytical study.
  14. Association of thyroid dysfunction with diffuse hair loss among patients undergoing clinically indicated thyroid testing: a cross-sectional analytical study.
  15. Clinical and trichoscopic characteristics of diffuse hair loss in patients with and without anaemia: a comparative cross-sectional study.
  16. Quality-of-life impairment in patients with telogen effluvium and its association with duration and severity of hair shedding: a cross-sectional analytical study.
  17. Pattern of self-medication and nutritional supplement use among patients presenting with diffuse hair loss: a cross-sectional observational study.
  18. Association of dietary patterns with telogen effluvium among adult women attending a dermatology clinic: a case-control study.
  19. Short-term change in hair pull test and patient-reported hair shedding after correction of an identified routine clinical trigger in telogen effluvium: a prospective observational study.
  20. Baseline clinical predictors of improvement in hair shedding over twelve weeks among patients with telogen effluvium receiving routine management: a prospective observational study.

Scarring Alopecia, Traction Alopecia and Hair-Shaft Disorders

  1. Clinical and trichoscopic profile of primary cicatricial alopecia in patients attending a dermatology outpatient department: a cross-sectional observational study.
  2. Correlation of trichoscopic findings with routine histopathology in primary cicatricial alopecia among patients undergoing clinically indicated scalp biopsy: a cross-sectional analytical study.
  3. Diagnostic accuracy of trichoscopy in identifying cicatricial alopecia using clinical examination and histopathology where clinically indicated as the reference standard: a diagnostic accuracy study.
  4. Comparison of trichoscopic findings in lichen planopilaris and discoid lupus erythematosus of the scalp: a comparative cross-sectional study.
  5. Correlation of perifollicular scaling and erythema on trichoscopy with histopathological inflammatory activity in lichen planopilaris among patients undergoing clinically indicated biopsy: a correlation study.
  6. Clinical and trichoscopic profile of frontal fibrosing alopecia in women: a cross-sectional observational study.
  7. Association of eyebrow involvement with clinical severity of frontal fibrosing alopecia: a cross-sectional analytical study.
  8. Clinical and trichoscopic profile of central centrifugal cicatricial alopecia among patients presenting to a dermatology centre: a cross-sectional observational study.
  9. Clinicopathological concordance in primary cicatricial alopecia among patients undergoing routine diagnostic scalp biopsy: a retrospective observational study.
  10. Clinical predictors of permanent hair loss among patients with cicatricial alopecia: a cross-sectional analytical study.
  11. Clinical and trichoscopic profile of traction alopecia in women: a cross-sectional observational study.
  12. Association of hair-grooming practices with traction alopecia: a case-control study.
  13. Comparison of trichoscopic findings in early and late traction alopecia: a comparative cross-sectional study.
  14. Association of duration and frequency of traction-producing hairstyles with severity of traction alopecia: a cross-sectional analytical study.
  15. Clinical and trichoscopic differentiation of traction alopecia from frontal fibrosing alopecia: a comparative cross-sectional study.
  16. Clinical and trichoscopic profile of trichotillomania in patients presenting with patchy alopecia: a cross-sectional observational study.
  17. Comparison of trichoscopic findings in trichotillomania and alopecia areata: a comparative cross-sectional study.
  18. Diagnostic accuracy of trichoscopy for trichotillomania using clinical assessment and histopathology where clinically indicated as the reference standard: a diagnostic accuracy study.
  19. Clinical and trichoscopic spectrum of acquired hair-shaft abnormalities among patients presenting with hair breakage: a cross-sectional observational study.
  20. Association of cosmetic hair practices with acquired hair-shaft damage identified on clinical examination and trichoscopy: a case-control study.

Paediatric Alopecia, Pattern Comparison and Treatment-Related Studies

  1. Clinical and trichoscopic spectrum of alopecia in children attending a dermatology outpatient department: a cross-sectional observational study.
  2. Relative frequency and clinical characteristics of non-scarring alopecia in children: a cross-sectional observational study.
  3. Comparison of clinical and trichoscopic findings in paediatric alopecia areata and tinea capitis: a comparative cross-sectional study.
  4. Diagnostic accuracy of trichoscopy in differentiating alopecia areata from tinea capitis in children using potassium hydroxide examination and fungal culture when clinically indicated as the reference standard: a diagnostic accuracy study.
  5. Clinical and trichoscopic profile of tinea capitis presenting with alopecia in children: a cross-sectional observational study.
  6. Correlation of trichoscopic findings with potassium hydroxide examination in children with clinically suspected tinea capitis: a cross-sectional analytical study.
  7. Association of household contact history and hair-sharing practices with tinea capitis presenting as alopecia in children: a case-control study.
  8. Clinical and trichoscopic characteristics of alopecia areata in children and their correlation with Severity of Alopecia Tool score: a cross-sectional analytical study.
  9. Association of nail involvement with severity of paediatric alopecia areata: a cross-sectional analytical study.
  10. Quality-of-life impairment in children with alopecia areata using Children's Dermatology Life Quality Index and its correlation with disease severity: a cross-sectional analytical study.
  11. Comparison of clinical and trichoscopic characteristics of alopecia areata in children and adults: a comparative cross-sectional study.
  12. Comparison of trichoscopic patterns across androgenetic alopecia, alopecia areata and telogen effluvium: a comparative cross-sectional study.
  13. Diagnostic utility of selected trichoscopic features in common non-scarring alopecias using clinical diagnosis as the reference standard: a diagnostic accuracy study.
  14. Concordance between clinical diagnosis and trichoscopic diagnosis in patients presenting with non-scarring alopecia: a cross-sectional analytical study.
  15. Pattern of over-the-counter hair-loss remedies and self-medication among patients presenting with alopecia: a cross-sectional observational study.
  16. Frequency and determinants of inappropriate topical corticosteroid use among patients presenting with alopecia: a cross-sectional analytical study.
  17. Adherence to prescribed treatment among patients with common non-scarring alopecias and factors associated with poor adherence: a cross-sectional analytical study.
  18. Comparison of Dermatology Life Quality Index across androgenetic alopecia, alopecia areata and telogen effluvium: a comparative cross-sectional study.
  19. Association of patient-perceived hair-loss severity with objectively assessed clinical and trichoscopic severity in common non-scarring alopecias: a cross-sectional analytical study.
  20. Early clinical and trichoscopic changes over twelve weeks among patients with common non-scarring alopecias receiving diagnosis-specific routine therapy: a prospective observational study.

Not the dermatology subspeciality you need? Alopecia is one section of our full dermatology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.

Browse all Dermatology Thesis Topics →

📌 Updated for 2026–2027 MD Dermatology Alopecia admissions

The proposed designs were reviewed for feasibility in routine dermatology departments, with particular attention to trichoscopy, disease-specific grading, diffuse hair-loss differentials, clinicopathological correlation and early treatment follow-up.

  • Most topics can be completed with clinical examination, hair pull testing, trichoscopy, routine laboratory investigations and scalp biopsy only when already clinically indicated.
  • Advanced hormonal panels, genetic testing, specialised hair-count devices and research-only biopsy are generally not required for a feasible residency project.
  • Publication potential is strongest when the diagnostic reference standard, scalp sampling method and primary severity or activity measure are defined before enrolment.
Generate a protocol from any topic above

Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:

  • Introduction / Synopsis
  • Research Question
  • Aim of the Study
  • Primary Objective
  • Secondary Objectives
  • Materials and Methods
  • Inclusion Criteria
  • Exclusion Criteria
  • Sample Size Calculation
  • Methodology
  • Statistical Analysis
  • Ethical Considerations
  • Review of Literature
  • References
  • Gantt Chart / Study Timeline
  • Patient Information Sheet
  • Consent Form
  • Data Collection Form

Already have your thesis title?

Generate the full alopecia protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Alongside alopecia protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

Alopecia research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the alopecia research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the alopecia research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare an alopecia research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A alopecia IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning alopecia research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the alopecia research proposal is the document assessed at the start of it.

Kuwait — KIMS. A alopecia study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the alopecia proposal follows the same structure throughout.

Generate an alopecia research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A alopecia dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full alopecia research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.

Enquire about an alopecia PhD or MMed proposal →

🔥 Trending research areas in Alopecia for 2026–27

  • Trichoscopic differentiation of common non-scarring alopecias remains valuable because early female pattern hair loss, chronic telogen effluvium, alopecia areata and trichotillomania may overlap clinically.
  • Activity markers in cicatricial alopecia are important because treatment decisions depend more on active perifollicular inflammation than on the amount of established permanent hair loss.
  • Real-world treatment response and adherence studies are useful because topical minoxidil and intralesional corticosteroid outcomes are strongly influenced by persistence with treatment and baseline disease severity.
  • Metabolic and quality-of-life associations in patterned hair loss continue to be relevant when the project separates association from causation and avoids unnecessary screening outside routine clinical indications.

Protocol and synopsis guidance

What an alopecia protocol must contain

An alopecia protocol should first define whether the study concerns non-scarring alopecia, cicatricial alopecia, diffuse shedding, patterned hair loss, paediatric alopecia or a specific differential diagnosis. The inclusion criteria should state how the diagnosis is established and which previous treatments, cosmetic practices or systemic conditions are permitted.

Diagnostic framework: Clinical examination, hair pull testing, trichoscopy, potassium hydroxide examination, fungal culture and histopathology should not be treated as interchangeable. If diagnostic accuracy is claimed, the protocol must name an independent reference standard and explain what happens when confirmatory testing is performed only in selected patients.

Severity measurement: Hamilton-Norwood, Ludwig and SALT grading answer different questions and apply to different diseases. Hair shedding reported by the patient is not equivalent to measured density, shaft-diameter diversity or hair pull positivity. The primary outcome and assessor should therefore be fixed before enrolment.

Trichoscopy and biopsy: State the scalp sites, magnification, image acquisition method and whether the same sites are re-examined at follow-up. In suspected cicatricial alopecia, record how the biopsy site is chosen because an inactive scarred centre can miss diagnostic perifollicular inflammation.

Alopecia synopsis versus alopecia protocol

An alopecia synopsis gives the committee the research question, rationale, objectives, design, broad methods, sample size, statistical plan and ethical safeguards in a compact format. It should show that the project is feasible within the available patient load and investigation pathway.

The full protocol must define the diagnostic criteria that separate commonly overlapping entities such as female pattern hair loss, chronic telogen effluvium, alopecia areata, trichotillomania, traction alopecia and early cicatricial alopecia. It should also state exactly how severity, activity and treatment response are measured.

For trichoscopy-based studies, the full protocol should specify scalp mapping, magnification, image storage and assessor blinding where feasible. For biopsy-based studies, it should record the clinical indication and biopsy-site selection. These details are essential because otherwise the study can appear reproducible in the synopsis but become methodologically inconsistent during recruitment.

Sample size and statistical analysis

Sample size should be driven by the primary objective. A prevalence or profile study needs an expected proportion and precision; a comparison of two alopecia groups needs an anticipated difference in the chosen clinical or trichoscopic outcome; a case-control study needs an expected exposure difference; and a prospective response study needs an expected change in the predefined outcome.

Severity grades such as Hamilton-Norwood, Ludwig or SALT should be analysed according to their scale and distribution. Correlation between two measures does not establish agreement, and concordance between clinical and trichoscopic diagnosis may require agreement statistics rather than sensitivity and specificity unless an independent reference standard exists.

Repeated clinical or trichoscopic observations require paired or longitudinal analysis. Multivariable models should remain realistic for the available sample and should account for clinically important confounders such as age, sex, disease duration, prior treatment, anaemia, thyroid disease, metabolic factors or grooming practices when relevant to the research question.

Frequently Asked Questions – Alopecia Thesis Topics (2026–27)

1. How should I choose a feasible alopecia thesis topic for 2026–2027 MD Dermatology admissions?

Choose a question that matches the department's actual hair-loss case-load and the diagnostic tools already available, such as clinical examination, hair pull testing, trichoscopy, routine laboratory investigations and scalp biopsy when clinically indicated. A feasible alopecia thesis should focus on one clearly defined disease group or differential diagnosis, use a reproducible primary outcome and avoid depending on advanced laboratory tests or prolonged follow-up that cannot be completed within one thesis period.

2. Which study designs are suitable for an alopecia thesis?

Cross-sectional observational and analytical studies suit clinical profiling, trichoscopic patterns, severity correlations, quality of life and associated conditions. Comparative cross-sectional designs work well for common differentials such as female pattern hair loss versus chronic telogen effluvium or alopecia areata versus trichotillomania. Case-control studies are useful for risk factors such as grooming practices, metabolic syndrome or nutritional exposures. Prospective observational studies can assess early clinical and trichoscopic response, adherence and adverse effects during routine treatment.

3. What should I settle with my guide before finalising an alopecia thesis protocol?

Define the exact alopecia phenotype, age range, disease duration, previous treatment, primary outcome, grading system and diagnostic reference standard before recruitment. State whether diagnosis rests on clinical examination, trichoscopy, hair pull testing, potassium hydroxide examination, fungal culture, histopathology or a predefined combination. For serial studies, fix the scalp sites, trichoscopic magnification, image method and follow-up interval so that baseline and follow-up assessments are comparable.

4. How can I make a retrospective alopecia study reliable?

Retrospective alopecia research is feasible when records contain a reproducible diagnosis, baseline severity, treatment exposure and sufficiently standardised photographs or trichoscopic images. It becomes weak when diagnostic labels were used inconsistently or when key distinctions, such as scarring versus non-scarring alopecia, were not documented. For cicatricial alopecia, retrospective histopathology can be useful only when the biopsy site and clinicopathological diagnosis are traceable.

5. What is the difference between an alopecia synopsis and an alopecia protocol?

The synopsis is the concise academic submission that summarises the research question, rationale, objectives, methods, sample size, analysis and ethics. The full protocol is the operational document and should specify diagnostic criteria, grading systems, scalp sites, hair pull method, trichoscopic acquisition, biopsy indications, treatment-exposure definitions, follow-up windows and statistical methods in enough detail for another investigator to reproduce the study.

6. What ethical issues should an alopecia thesis address?

For children, guardian consent and child assent from about seven years should be addressed according to institutional policy. Record-based work may seek a waiver of consent where permitted. Research should not add scalp biopsy, blood tests, fungal investigations or treatment solely for study purposes unless specifically justified and approved; any research-only venepuncture should state the blood volume limit. Separate consent should be obtained for identifiable scalp or facial photographs and video. Images must be de-identified and stored securely. The protocol should also state how clinically important incidental findings, such as suspected tinea capitis, thyroid disease, anaemia, severe treatment-related adverse effects or signs of active cicatricial alopecia, will be escalated for appropriate clinical care.

7. What is the sharpest methodological problem in alopecia research?

The sharpest problem is circular diagnosis when the same clinical or trichoscopic features are used both to define the disease and then to test the diagnostic performance of those features. A diagnostic-accuracy study must specify an independent reference standard. In cicatricial alopecia, biopsy-site selection is equally important because sampling a fully scarred inactive centre may miss perifollicular inflammation and produce misleading clinicopathological discordance. The protocol should state where and how the biopsy site is selected, preferably from an active margin when clinically indicated.

8. Can an alopecia topic be adapted for PhD, Saudi Board, Arab Board or Gulf research requirements?

Yes. An MD synopsis generally asks a focused clinical question that can be completed within residency, whereas a PhD research proposal requires a broader conceptual framework, deeper methodological justification and usually a programme of work. Board pathways may also require a separate research project. This includes SCFHS and Saudi Board requirements, the Arab Board of Health Specializations, and research components linked to DHP, DHA, DOH and MOHAP training programmes. The same core alopecia question can often be retained, but governance, sample size justification, methodological detail and expected output should be adapted to the relevant institution or board.

9. When should I register my alopecia thesis study?

Registration and institutional approvals should be completed before prospective recruitment or study-specific data collection begins. The final protocol, diagnostic criteria, grading system, image method, biopsy pathway where relevant and statistical plan should be settled first so that the registered study matches the work actually performed. Retrospective projects should have ethics and data-access requirements clarified before identifiable records or images are extracted.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.

Generate your protocol
Don`t copy text!
Generate Thesis Protocol / Synopsis
×